复方甲氧那明和左氧氟沙星治疗上呼吸道感染后咳嗽及对临床控制率影响分析

Analysis of the effect of compound methoxamine and levofloxacin on cough after upper respiratory tract infection and clinical control rate

目的 探究对上呼吸道感染后咳嗽患者实施复方甲氧那明联合左氧氟沙星治疗的效果和价值。方法回顾性方式纳入我院2019年6月~2021年8月内80例上呼吸道感染后咳嗽患者随机分组,其中对照组38例给予右美沙芬口服液治疗,观察组42例给予复方甲氧那明联合左氧氟沙星治疗,观察疾病临床控制率。结果 观察组临床控制率高达95.2%,对照组仅78.9%,且经治疗后观察组患者日间/夜间咳嗽症状、咳痰症状积分较低,两组数据对比,P<0.05。结论 复方甲氧那明联合左氧氟沙星治疗上呼吸道感染后咳嗽效果显著,值得临床推广并借鉴。

Objective To explore the effect and value of compound methoxamine combined with levofloxacin in the treatment of patients with cough after upper respiratory tract infection. Methods 80 patients with cough after upper respiratory tract infection in our hospital from June 2019 to August 2021 were randomly divided into two groups. Among them, 38 patients in the control group were treated with dextromethorphan oral liquid, and 42 patients in the observation group were treated with compound methonamine combined with levofloxacin. Observe the clinical control rate of the disease. Results The clinical control rate of the observation group was as high as 95.2%, and that of the control group was only 78.9%. After treatment, the observation group had lower scores of daytime/night cough and sputum symptoms.The comparison of the two groups’ data, P<0.05. Conclusion The compound methoxyphenamine combined with levofloxacin is effective in treating cough after upper respiratory tract infection, which is worthy of clinical promotion and reference.